J Can Acad Child Adolesc Psychiatry. 2017;26(3):233-240. Epub 2017 Oct 01.
Adjunctive Trazodone and Depression Outcome in Adolescents Treated with Serotonin Re-uptake Inhibitors.
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent
Meshal A Sultan, Darren B Courtney
Affiliations
Affiliations
- Child and Adolescent Psychiatrist, Mental Health Centre of Excellence, Al Jalila Children's Speciality Hospital, Dubai, UAE.
- Formerly a Subspecialty Fellow, Child and Adolescent Psychiatry Program, Department of Psychiatry, University of Ottawa, Ottawa, Ontario.
- Assistant Professor, Department of Psychiatry, University of Toronto, Toronto, Ontario.
PMID: 29056986
PMCID: PMC5642463
Abstract
OBJECTIVES: Recent published evidence suggests that adjunctive trazodone treatment may limit serotonin reuptake inhibitor (SRI) response in depressed adolescents in the context of a controlled trial. This study examined the effects of adjunctive trazodone on depression outcome in adolescents in a naturalistic treatment environment.
METHODS: We conducted a cohort study through chart review of a clinical sample. Patients in our sample were 15 to 18 years of age treated with either a selective serotonin reuptake inhibitor or serotonin and norepinephrine reuptake inhibitor. The treatment took place in the setting of a partial hospitalization program at a tertiary care centre from 2009-2014. The main outcome measure was the change in Beck Depression Inventory II (BDI-II) score from admission to discharge. We compared this outcome in patients who were exposed to adjunctive trazodone treatment compared to adolescents who did not receive trazodone in the final four weeks of the program.
RESULTS: Exposure to trazodone was significantly associated with non-response to treatment in our sample (n= 35; β
CONCLUSION: In keeping with previous research, we found that trazodone exposure was associated with treatment non-response in adolescents taking SRIs. The findings should be interpreted cautiously since they are limited by small sample size. Future randomized controlled trials of trazodone in samples of adolescents taking SRIs for depression are warranted.
Keywords: adolescent; depression; selective serotonin re-uptake inhibitor; trazodone; treatment-resistant depression
References
- Am J Psychiatry. 2010 Jul;167(7):782-91 - PubMed
- J Clin Psychiatry. 1990 Apr;51 Suppl:14-20; discussion 21 - PubMed
- J Clin Psychopharmacol. 1997 Oct;17(5):358-64 - PubMed
- J Child Adolesc Psychopharmacol. 2012 Feb;22(1):29-36 - PubMed
- Can J Psychiatry. 2016 Sep;61(9):540-60 - PubMed
- JAMA. 2008 Feb 27;299(8):901-13 - PubMed
- Sleep Med. 2010 Aug;11(7):692-700 - PubMed
- Fundam Clin Pharmacol. 1996;10(1):16-27 - PubMed
- J Child Adolesc Psychopharmacol. 2012 Feb;22(1):21-8 - PubMed
- Depress Anxiety. 2011 Nov;28(11):946-54 - PubMed
- J Clin Psychol Med Settings. 2008 Sep;15(3):225-33 - PubMed
- J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26 - PubMed
- Psychol Assess. 2004 Jun;16(2):120-32 - PubMed
- Br J Psychiatry. 2002 May;180:396-404 - PubMed
- J Clin Psychopharmacol. 2015 Jun;35(3):296-303 - PubMed
- BMJ. 2009 Aug 11;339:b2880 - PubMed
- BMJ. 1995 Apr 8;310(6984):897-901 - PubMed
- J Clin Psychol. 2000 Apr;56(4):545-51 - PubMed
- J Affect Disord. 1996 Dec 16;41(3):201-10 - PubMed
- J Pharmacol Exp Ther. 2010 Oct;335(1):197-206 - PubMed
Publication Types